Introduction
The number of new spinal cord injuries in the United States continues to increase each year. 1 Deep vein thrombosis (DVT) and pulmonary embolism (PE) are the major post injury complications in the Frankel A, B, and C groups with an incidence ranging from 49% to 72% (Table 1) .2-5 They will usually occur in the first 2 weeks following injury.5.6 Various modalities of prophylaxis adapted from the surgical literature such as subcutaneous heparin (5,000 u, SC, Q8 hrs) and warfarin have been ineffective in redu cing the incidence of DVT in this popula tion.5-7 More recently, combination thera pies which reduce stasis and hypercoagul ability have achieved a successful reduction in the incidence of DVT and PE but have not gained widespread acceptance.5•8 Rea sons for this may be the lack of knowledge of the defined risk of DVTjPE, difficulty in application of prophylactic devices, or placement of the patient into aggressive rehabilitation programs. The purpose of this pilot study is to assess the combination of external pneumatic compression (EPC) sleeves plus gradient elastic stockings (GES) and subcutaneous low dose heparin (LDH) as prophylaxis for DVT in the first 2 weeks following acute SCI.
Methodology
Patients were included in the study if they were older than age 15 and had incurred a C2 through T12 motor complete or motor Patients received prophylaxis with EPC plus GES and LDH. EPC was accomplished using a knee length sequential compression device (Kendall, Boston, Mass). The GES were calf length (Carolan's Type 511). The combination of sleeves and stockings were worn 23 hours per day with one hour off for skin care and bathing. Heparin sodium (Wyeth-Ayerst Laboratories, Philadelphia, PA) was administered at a dose of 5,000 units subcuntaneously in the abdomen on a 12 hour schedule at 0800 hrs and 2000 hrs daily. If patients underwent surgery, the morning dose was given 2 hours prior to surgery. 125 I fibrinogen scanning using the method of Kakkar9 was initiated within 18 hours of admission and performed daily for 2 weeks. The criteria for diagnosis of DVT was an increased uptake of 20% or more on 2 consecutive measurements compared with adjacent readings. All positive studies were confirmed by venography. All venograms were completed via the Rabinov et al technique and scored by the modified Marder et al deerc vein thrombosis scoring scale (Table II) .
0.11 All venograms were interpreted by a blinded observer.
The 21 consecutive patients corresponded
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closely with respect to age, sex, level of lesion, surgery and length of 125 I fibri nogen scanning to our previously reported control group (Fig 1) .5 This control group of 17 patients was used for comparison to our treatment group. The Fischer's Exact Test with a two-tailed probability was used to compare the incidence of DVT between the treated and control groups. The Ordered Chi Square Test that considers trend with a two-tailed probability was utilized to com pare the degree of thrombosis demonstrated in each of the 2 groups.
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Results
Twenty-one consecutive patients entered the protocol within 72 hours of acute spinal cord injury. There were 5 women and 16 men ranging in age from 18 to 70 years. The level of injury included 16 cervical and 5 thoracic lesions (Table III) . Two patients were not included in the evaluation because they violated the 72 hour entry window for initiating prophylaxis with EPC + LDH + GES. One patient had been delayed 96 hours before EPC sleeves were placed and the second did not receive LDH for 96 hours. These patients did not remain part of the protocol and received the standard therapy of the center (EPC + LDH). One of the 2 developed a thrombosis 9 days post injury. Of the 19 evaluable patients, 17 (89%) had negative fibrinogen scanning upon completion of the study. The 2 re maining patients (11% ) developed a posit ive fibrinogen scan on days 6 and 8 of the study (Fig 1) . Venography was performed and demonstrated acute thrombosis in only one of these patients (5.2% ) (Fig 1) . The thrombosis involved the tibialis anterior vein with a modified Marder Scale score of eight. In comparison, the control group developed positive 125 I fibrinogen scans in 6/17 (35% ) patients and all were confirmed by venography (Fig 1) . The six thrombi found in the control group ranged from 8 to 40 on the Marder scoring scale with scores of 8, 10, 20, 24, 34, 40 (Fig 2) . This incidence of thrombosis was significantly different than that of the treated group (p = 0.04). The extent of the clot was then compared between the 2 groups using a modified Marder score of <10 as minimal clot and > 10 substantial clot. Using these assumptions a significant difference was found in the extent of clot between the 2 groups in favor of the EPC plus GES and LDH treated group (p = 0.02).
Discussion
Approaches to prophylaxis for DVT have varied from no treatment to single agent or combination modalities.13 These methods have attempted to improve one or more arms of Virchow's Triad which includes stasis, hypercoagulability, and intimal in jury. Early DVT prophylaxis studies utilized subcutaneous heparin or warfarin to reduce hypercoagulability with the efficacy of treat ment assessed clinically and not by diag nostic tests.14.15 A more rigorous placebo controlled study was completed using low dose heparin (5,000 units, SC, Q8 hrs) as the sole prophylactic agent.5 Effectiveness of therapy was confirmed by venography. The incidence of DVT was 49% in the placebo group and 52% in the heparin group, a nonsignificant difference. Green et al reported the use of adjusted dose sub cutaneous heparin versus low dose heparin as a prophylaxis for DVT in acute spinal cord injured patients. 16 This method utilized a standard dose of heparin which was adjusted on a sliding scale to maintain the PTT in the top normal range of the laborat ory. This prophylaxis reduced the incidence from 31 % in the low dose heparin group to 7% in the adjusted dose heparin group. Although this form of treatment was effect ive, it was associated with a high incidence of bleeding complications (24% ) for which prophylaxis had to be discontinued. These results raised the issue concerning the need for the evaluation of combination therapy or better dosing of single pharmacological ag ents for prophylaxis. More recent studies regarding hyper coagulability in spinal cord injured patients have demonstrated an increase in platelet aggregation with a resultant increase in the risk of developing DVT. 6 Using this finding Green et at compared EPC to EPC plus aspirin/dipyridamole as prophylaxis for DVT in acute SCI. 8 125 I fibrinogen scan ning with confirmatory venography for positive scans was utilized to assess the efficacy of these prophylactic measures. DVT was reduced from 72% in the previously studied control group reported by the author to 35% in the EPC alone group and 25% in the EPC plus aspirin/dipyridamole group.
Another approach to combination pro phylactic measures to reduce both stasis and hypercoagulability employed electrical stimulation (ES) of the calf plus low dose heparin (5,000 units, SC, 08 hrs).5 In this randomized, prospective, placebo con trolled study all patients were evaluated for 4 weeks following acute SCI by surveillance 125 I fibrinogen scanning. Bilateral leg venography was performed upon comple tion of the protocol. All positive 125 I fibrinogen scans prior to completion of the study were confirmed by venography. This mode of prophylaxis reduced the incidence of DVT from 49% in the placebo group to 6.7% in the treated group.
In the previously reported studies by Merli et at and Rossi et at DVT was reported to occur most frequently during the first 2 weeks following spinal cord injury.5, 6 Merli et at reported a 54% incid ence between days 3 through 7 and 33% days 8 through 14. 17 Rossi et al noted a 62% incidence between day 6 to 8 and a 23% incidence day 9 through 14.6 Using this data it was decided that 14 days was an adequate study period.
The present study examines a different combination regimen for DVTjPE prophy laxis namely EPC, GES, and LDH. EPC has been shown to enhance venous blood flow in the lower extremities. This mechan ical modality used alone as prophylaxis in neurosurgical, orthopedic, urological, and acute SCI patients has been shown to significantly decrease the incidence of DVT.18-20 Unlike electrical stimulation, which cannot be used in sensory intact candidates, EPC can be applied to all types of patients. GES were added to further enhance the reduction of stasis. This modal ity has been demonstrated to be effective in low risk surgery. 21 The combination of the References Prophylaxis of deep vein thrombosis 561 above modalities is designed to reduce stasis, one of the major arms of Virchow's Triad. Low dose heparin (5,000 U, SC, 012 hrs) was chosen for its effect on redu cing hypercoagulability, another arm of Virchow's Triad. The rationale for low dose heparin is the reduction of activated factor Xa, resulting in decreased generation of thrombin and clot formation. 22 This phar macological agent has demonstrated effect iveness in multiple surgical studies and is far more effective in reducing DVT in the surgical population than aspirin or dipyrida mole alone or in combination. 23,24 The every 12 hours dosing schedule for low dose heparin was chosen instead of the every 8 hours for ease of administration since neither regimen has been shown to be more effective than the other. 25 Low dose heparin alone has not been shown to decrease the incidence of DVT in the acute SCI popula tion.5 The combination of low dose heparin to decrease hypercoagulability and EPC plus GES to decrease stasis in this study demonstrated a decrease in both the number and size of thrombi when compared to a historical control group. This decrease in size of thrombi may be an important finding since no other study in this popula tion has demonstrated this change. The results indicate that this combination therapy may be a more effective approach to prophylaxis in the spinal cord injury population. Because this study has such a small sample size and utilized an historical control, a proper prospective, randomized trial will be necessary to confirm the efficacy of combination therapy in acute spinal cord injury,
